As of April 29, 2025, Xenetic Biosciences (XBIO) has a market cap of $4.411 million USD. According to our data, Xenetic Biosciences is ranked No.9044 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $4.41 M |
-28.32%
|
Dec 31, 2024 | $6.15 M |
15.65%
|
Dec 29, 2023 | $5.32 M |
21.05%
|
Dec 30, 2022 | $4.40 M |
-77.91%
|
Dec 31, 2021 | $19.89 M |
-36.76%
|
Dec 31, 2020 | $31.46 M |
41.67%
|
Dec 31, 2019 | $22.21 M |
-92.68%
|
Dec 31, 2018 | $0.30 B |
-14.54%
|
Dec 29, 2017 | $0.36 B |
-55.37%
|
Dec 30, 2016 | $0.80 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amgen
AMGN
|
$152.20 B |
0.126 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.59 B |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$62.20 B |
1.034 B
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$127.64 B |
0.004 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$12.13 B |
0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.69 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$33.29 B |
-0.001 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.76 B |
0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.98 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.34 M |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.23 B |
-0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.85 B |
-0.000 M
|
![]() USA
|
Market Cap | = | XBIO Stock Price | * | XBIO Shares Outstanding |
= | $2.86 | * | 1.54 M | |
= | $4.41 M |